Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats.
Pulmonary artery smooth muscle cells (PA-SMCs) in pulmonary arterial hypertension (PAH) show similarities to cancer cells. Due to the growth-suppressive and pro-apoptotic effects of p53 and its inactivation in cancer, we hypothesized that the p53 pathway could be altered in PAH. We therefore explore...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4488287?pdf=render |
| _version_ | 1819213300884307968 |
|---|---|
| author | S Jacquin V Rincheval B Mignotte S Richard M Humbert O Mercier A Londoño-Vallejo E Fadel S Eddahibi |
| author_facet | S Jacquin V Rincheval B Mignotte S Richard M Humbert O Mercier A Londoño-Vallejo E Fadel S Eddahibi |
| author_sort | S Jacquin |
| collection | DOAJ |
| description | Pulmonary artery smooth muscle cells (PA-SMCs) in pulmonary arterial hypertension (PAH) show similarities to cancer cells. Due to the growth-suppressive and pro-apoptotic effects of p53 and its inactivation in cancer, we hypothesized that the p53 pathway could be altered in PAH. We therefore explored the involvement of p53 in the monocrotaline (MCT) rat model of pulmonary hypertension (PH) and the pathophysiological consequences of p53 inactivation in response to animal treatment with pifithrin-α (PFT, an inhibitor of p53 activity).PH development was assessed by pulmonary arterial pressure, right ventricular hypertrophy and arterial wall thickness. The effect of MCT and PFT on lung p53 pathway expression was evaluated by western blot. Fourteen days of daily PFT treatment (2.2 mg/kg/day), similar to a single injection of MCT (60 mg/kg), induced PH and aggravated MCT-induced PH. In the first week after MCT administration and prior to PH development, p53, p21 and MDM2 protein levels were significantly reduced; whereas PFT administration effectively altered the protein level of p53 targets. Anti-apoptotic and pro-proliferative effects of PFT were revealed by TUNEL and MTT assays on cultured human PA-SMCs treated with 50 μM PFT.Pharmacological inactivation of p53 is sufficient to induce PH with a chronic treatment by PFT, an effect related to its anti-apoptotic and pro-proliferative properties. The p53 pathway was down-regulated during the first week in the rat MCT model. These in vivo experiments implicate the p53 pathway at the initiation stages of PH pathogenesis. |
| first_indexed | 2024-12-23T06:56:41Z |
| format | Article |
| id | doaj.art-8c02400444784a4593e0cf2dfe9d14a4 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-23T06:56:41Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-8c02400444784a4593e0cf2dfe9d14a42022-12-21T17:56:18ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01106e013194010.1371/journal.pone.0131940Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats.S JacquinV RinchevalB MignotteS RichardM HumbertO MercierA Londoño-VallejoE FadelS EddahibiPulmonary artery smooth muscle cells (PA-SMCs) in pulmonary arterial hypertension (PAH) show similarities to cancer cells. Due to the growth-suppressive and pro-apoptotic effects of p53 and its inactivation in cancer, we hypothesized that the p53 pathway could be altered in PAH. We therefore explored the involvement of p53 in the monocrotaline (MCT) rat model of pulmonary hypertension (PH) and the pathophysiological consequences of p53 inactivation in response to animal treatment with pifithrin-α (PFT, an inhibitor of p53 activity).PH development was assessed by pulmonary arterial pressure, right ventricular hypertrophy and arterial wall thickness. The effect of MCT and PFT on lung p53 pathway expression was evaluated by western blot. Fourteen days of daily PFT treatment (2.2 mg/kg/day), similar to a single injection of MCT (60 mg/kg), induced PH and aggravated MCT-induced PH. In the first week after MCT administration and prior to PH development, p53, p21 and MDM2 protein levels were significantly reduced; whereas PFT administration effectively altered the protein level of p53 targets. Anti-apoptotic and pro-proliferative effects of PFT were revealed by TUNEL and MTT assays on cultured human PA-SMCs treated with 50 μM PFT.Pharmacological inactivation of p53 is sufficient to induce PH with a chronic treatment by PFT, an effect related to its anti-apoptotic and pro-proliferative properties. The p53 pathway was down-regulated during the first week in the rat MCT model. These in vivo experiments implicate the p53 pathway at the initiation stages of PH pathogenesis.http://europepmc.org/articles/PMC4488287?pdf=render |
| spellingShingle | S Jacquin V Rincheval B Mignotte S Richard M Humbert O Mercier A Londoño-Vallejo E Fadel S Eddahibi Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats. PLoS ONE |
| title | Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats. |
| title_full | Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats. |
| title_fullStr | Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats. |
| title_full_unstemmed | Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats. |
| title_short | Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats. |
| title_sort | inactivation of p53 is sufficient to induce development of pulmonary hypertension in rats |
| url | http://europepmc.org/articles/PMC4488287?pdf=render |
| work_keys_str_mv | AT sjacquin inactivationofp53issufficienttoinducedevelopmentofpulmonaryhypertensioninrats AT vrincheval inactivationofp53issufficienttoinducedevelopmentofpulmonaryhypertensioninrats AT bmignotte inactivationofp53issufficienttoinducedevelopmentofpulmonaryhypertensioninrats AT srichard inactivationofp53issufficienttoinducedevelopmentofpulmonaryhypertensioninrats AT mhumbert inactivationofp53issufficienttoinducedevelopmentofpulmonaryhypertensioninrats AT omercier inactivationofp53issufficienttoinducedevelopmentofpulmonaryhypertensioninrats AT alondonovallejo inactivationofp53issufficienttoinducedevelopmentofpulmonaryhypertensioninrats AT efadel inactivationofp53issufficienttoinducedevelopmentofpulmonaryhypertensioninrats AT seddahibi inactivationofp53issufficienttoinducedevelopmentofpulmonaryhypertensioninrats |